Left Menu
Development News Edition

Another Canadian citizen detained in China amid diplomatic row

A Canadian citizen has been detained in Yantai, a city in northeastern China, Global Affairs Canada said on Saturday.

ANI | Beijing | Updated: 14-07-2019 09:10 IST | Created: 14-07-2019 09:10 IST
Another Canadian citizen detained in China amid diplomatic row
Representative Image. Image Credit: ANI

A Canadian citizen has been detained in Yantai, a city in northeastern China, Global Affairs Canada said on Saturday. After quoting a spokesman for the Global Affairs Canada, CNN reported that Canadian officials are providing consular assistance to the man who has been arrested.

The detention comes amid heightened tensions between Ottawa and Beijing over the ongoing detention of Canadians Michael Kovrig and Michael Spavor, who have been held since December and were formally arrested in May on national security grounds. Kovrig and Spavor were detained following the arrest of Meng Wanzhou, the Chief Financial Officer of Chinese tech giant Huawei, in Canada.

Meng was taken into custody on December 1, 2018, in Vancouver on behalf of the United States on charges of suspected violations of US sanctions against Iran. She is currently awaiting trial. As relations between the two countries continued to worsen, last month China banned import of all meat from Canada claiming that customs documents had been forged by Canadian exporters.

There is currently no indication that the detention of the latest Canadian, who officials did not name citing privacy legislation, is related to the Kovrig and Spavor case. The move comes after police in the eastern Chinese province of Jiangsu arrested over a dozen foreigners on suspicion of drug offences.

On Friday, the UK Foreign Office said four British citizens had also been detained in Jiangsu. (ANI)


TRENDING

OPINION / BLOG / INTERVIEW

How UK’s 'best prepared' healthcare system failed to gauge COVID-19

The UK is proud of their public health system and its unlike any other country as around 90 percent of British public supports the founding principles of National Health Service. But without accurate data being available to stakeholders in ...

Poor on IHR capacity progress in 2019, WHO says Cambodia tops COVID-19 response

Despite being in proximity to Hubei, the original epicenter of COVID-19 pandemic, Cambodia has reported just 226 confirmed cases and zero deaths. After seeing the data, WHO appreciated Cambodias healthcare information system but experts dou...

Loopholes in Healthcare Information System may have failed Singapore COVID-19 model

In the initial days of the COVID-19 outbreak, Singapore was in the limelight for its effective healthcare system and pandemic response plan. However, Singapore has now joined the list of the worst-hit nations and the situation is even worse...

Australia's COVID-19 response: Digital infrastructure of help but implementation remains a challenge

Australias ongoing plans to upgrade its health information system helped by the Digital Health Strategy seem even more practical due to the pandemic. But as evident during the pandemic, administrative lapses and the complex matrix of power ...

Videos

Latest News

India's Wockhardt to supply millions of doses of COVID-19 vaccines to UK

Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple COVID-19 vaccines to the UK, including the one being developed by AstraZeneca and Oxford University, it said on Monday.The company has reserved fill-and-finish capacit...

Rising real lending rate roiling RBI rate cuts, scuppering credit offtake and growth: Report

Even after the Reserve Bank has slashed the key interest rates by 135 basis points bps since February this year, the real lending rates have only gone up by 44 bps in spite of nominal lending rates falling by 105 bps during the same period,...

Jharkhand CM greets people on Raksha Bandhan

Jharkhand Chief Minister Hemant Soren on Monday greeted people on the occasion of RakshaBandhanThe chief minister also advised the people tocelebrate the festival by staying at home in view ofCOVID-19 outbreakTaking to Twitter, Soren said, ...

Rival drugmakers launch joint trial of medicines for COVID-19

Rival drugmakers AbbVie Inc, Amgen Inc and Takeda Pharmaceuticals Inc on Monday said they have begun treating patients in a trial to quickly show whether a drug from each company can be repurposed and used against COVID-19, the disease caus...

Give Feedback